The malonyl CoA axis as a potential target for treating ischaemic heart disease.
about
Cardiac energy metabolic alterations in pressure overload-induced left and right heart failure (2013 Grover Conference Series)Recombinant yeast screen for new inhibitors of human acetyl-CoA carboxylase 2 identifies potential drugs to treat obesity.Treatment with the 3-ketoacyl-CoA thiolase inhibitor trimetazidine does not exacerbate whole-body insulin resistance in obese mice.4'-Chlorodiazepam, a translocator protein (18 kDa) antagonist, improves cardiac functional recovery during postischemia reperfusion in rats.DPP4 deficiency exerts protective effect against H2O2 induced oxidative stress in isolated cardiomyocytes.5'-AMP-activated protein kinase increases glucose uptake independent of GLUT4 translocation in cardiac myocytes.Hypercholesterolemia is associated with hyperactive cardiac mTORC1 and mTORC2 signaling.Mitochondria and the aging heart.A soluble receptor for advanced glycation end-products inhibits hypoxia/reoxygenation-induced apoptosis in rat cardiomyocytes via the mitochondrial pathway.Tracing cardiac metabolism in vivo: one substrate at a time.The emerging characterization of lysine residue deacetylation on the modulation of mitochondrial function and cardiovascular biology.Novel approach in LC-MS/MS using MRM to generate a full profile of acyl-CoAs: discovery of acyl-dephospho-CoAsThe impact of current and novel anti-diabetic therapies on cardiovascular risk.Mitochondrial dysfunction in non-alcoholic fatty liver disease and insulin resistance: cause or consequence?Fatty acid metabolism in pulmonary arterial hypertension: role in right ventricular dysfunction and hypertrophy.Antitumor effect of sinoporphyrin sodium-mediated photodynamic therapy on human esophageal cancer Eca-109 cells.Sweet as sugar: excessive glucose metabolism in the failing heart.Inhibition of serine palmitoyl transferase I reduces cardiac ceramide levels and increases glycolysis rates following diet-induced insulin resistance.Targeting energetic metabolism: a new frontier in the pathogenesis and treatment of pulmonary hypertension.Inhibition of carnitine palmitoyltransferase-1 activity alleviates insulin resistance in diet-induced obese mice.EphrinA1-Fc attenuates myocardial ischemia/reperfusion injury in mice.An LC-MS based untargeted metabolomics study identified novel biomarkers for coronary heart disease.Sonodynamic and photodynamic mechanisms of action of the novel hypocrellin sonosensitizer, SL017: mitochondrial cell death is attenuated by 11, 12-epoxyeicosatrienoic acid.Loss of Metabolic Flexibility in the Failing Heart.
P2860
Q26825047-D30D15BB-0D62-4F4D-9A70-12F9DB0BCA01Q33571309-BAC6E782-05C7-4D03-840A-BC19201F768BQ33603593-3C89EB89-2008-4380-8AB0-358773C563DCQ34111148-1CF4A090-A473-426B-83EA-4C6649F7B191Q34566411-6AF89BD7-6D14-42BE-9380-206A8AE86DF7Q35140908-9F5BD4A7-CE8D-41DE-865A-B8A2C33CDE72Q35840605-E82F7D90-D9B5-4A79-83F8-33582518A64CQ36077249-65DC6C0F-36EC-4852-B758-1CCBC2EAFE52Q36321887-51235F76-9C73-4F00-A61D-2FB690A507CBQ36726181-05A8C4AA-311D-4D63-B58F-A6AB6E544C21Q37398734-134BC437-4534-4C82-BC73-AB0460AC42DEQ37603251-7FC56225-36EC-43FB-8C24-408E202CB414Q38062033-6BE3AF88-A6BE-4152-8084-BD1AAD2A808BQ38126549-EDB9B00E-1628-4A26-AADB-613CD7816122Q38524717-80BC94D5-C71E-4214-B3D3-CC4630D92B26Q38964181-DFF00169-8776-4CDF-9442-0AEB64217C0DQ39116022-0E0FD58B-928C-4BF5-93A2-FC7723A8D963Q41813859-CCD614FB-FF55-46EF-ADDF-52D6184A759BQ42592575-4D1246B9-8162-4948-90CC-D25BFE9AB880Q43240756-701A78B9-8C05-4B26-870A-F8B7958CFFB0Q47115112-49C1C560-4B0E-4C06-9953-552FF1AADCAEQ51135560-3C4A967A-D94A-40AD-80F2-BECC39A20FD8Q53280942-B8045A4D-4FE5-409B-9073-073D925D6868Q55341036-A338B566-63D7-44A6-A7D1-D6C97A0C9A86
P2860
The malonyl CoA axis as a potential target for treating ischaemic heart disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The malonyl CoA axis as a potential target for treating ischaemic heart disease.
@en
The malonyl CoA axis as a potential target for treating ischaemic heart disease.
@nl
type
label
The malonyl CoA axis as a potential target for treating ischaemic heart disease.
@en
The malonyl CoA axis as a potential target for treating ischaemic heart disease.
@nl
prefLabel
The malonyl CoA axis as a potential target for treating ischaemic heart disease.
@en
The malonyl CoA axis as a potential target for treating ischaemic heart disease.
@nl
P2860
P356
P1476
The malonyl CoA axis as a potential target for treating ischaemic heart disease.
@en
P2093
Gary D Lopaschuk
John R Ussher
P2860
P304
P356
10.1093/CVR/CVN130
P577
2008-05-22T00:00:00Z